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A B S T R A C T   
Gastrointestinal manifestations of COVID-19 are rare and have primarily been limited to diarrhea or vomiting. 
Intussusception is the most common cause of bowel obstruction in infants, with up to 30% of pediatric intus-
susception cases having a preceding viral illness. We present the rare case of intussusception in a SARS-CoV-2 
positive infant. This is the first documented case of survival in a SARS-CoV-2 positive patient presenting with 
intussusception as the primary manifestation. As our knowledge of this disease evolves, surgeons need to remain 
suspicious for possible gastrointestinal manifestations of COVID-19.   
1. Introduction 
The COVID-19 pandemic has brought the world to a standstill, 
causing the loss of countless lives and wreaking financial havoc. It was 
first reported as a cluster of patients with severe pneumonia symptoms, 
linked to a seafood market in Wuhan, China. Caused by the Severe Acute 
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), it has spread to, as 
of 29th May 2020, 215 countries or territories and has resulted in 5.7 
million infected and over 350,000 deaths [1]. Symptoms range widely 
from mild, including fever, dry cough, dyspnea, myalgia, vomiting and 
diarrhea, to potentially fatal respiratory distress Respiratory symptoms 
are the most common. 
Children tend to be less likely to be COVID-19 positive and are 
usually afflicted with milder symptoms [2]. Among 44,762 laboratory 
confirmed cases from China, only 416 (1%) and 549 (1%) were from age 
groups <10 and 10–19 years [3]. Similar statistics have emerged from 
the USA. Out of 22,060 COVID-19 related hospitalizations between 
March 1st and March 16th, 2020, only 68 (0.003%) and 91 (0.004%) fell 
in the 0–4 and 5–17 years age groups. The cumulative rate per 100,000 
was thus 3.5 and 1.7 in 0–4 and 5-17 year-olds [4]. Furthermore, 
presence of symptoms was less frequent in children compared to adults, 
along with a shorter course of illness, as suggested by the fact that the 
median duration of fever was 3 days in children, compared to 10 days in 
adults [5]. Children with severe symptoms usually tend to have under-
lying medical conditions or comorbidities, with some children exhibit-
ing an insidious onset of respiratory symptoms, only being revealed after 
CT scans were conducted. A case series from the UK documented 8 
COVID-19 patients presenting with fever, abdominal pain and diarrhea 
with a working diagnosis of systemic sepsis secondary to suspected 
appendicitis [6]. This highlights the possible gastrointestinal compli-
cations that are possible with SARS-CoV-2 infection. Another case series 
of 5 pediatric patients presenting with non-respiratory symptoms was 
conducted in Wuhan, China. Of note, Case 1 in that series was of a 
10-month-old female with intussusception who tested positive for 
SARS-CoV-2 [7]. 
Intussusception is the most common cause of bowel obstruction in 
infants, most commonly occurring between the ages of 4 and 10 months 
[8]. Viral illnesses are known to cause intussusception. Its incidence 
ranges between 0.24 and 2.4 per 1000 live births, while the mortality 
rate is 2.1 per 1 million live births in the US. However, case fatality rates 
are much higher in Africa (9.4%) [9]. 
We present the unusual case of a patient with intussusception who 
was subsequently diagnosed to be SARS-CoV-2 positive. 
2. Case presentation 
A 4 months, 25 days old baby boy presented to the emergency room 
at Aga Khan University Hospital (AKUH), Karachi, Pakistan, with a two- 
day history of acute onset, intermittent, severe, crampy abdominal pain, 
accompanied by inconsolable crying and drawing up of the legs towards 
the abdomen and reluctance to feed. Each episode occurred at an in-
terval of 20–30 minutes and lasted for 15–20 minutes. With the passage 
of time, the episodes became more prolonged and severe. He had 
developed 2 episodes of per rectal bleeding in the preceding 24 hours 
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which was fresh but also mixed with mucoid stool (currant jelly). He was 
taken to a family physician and then spent 12 hours at a government 
hospital being treated for gastroenteritis. There was no fever, vomiting, 
or diarrhea. 
The child was otherwise healthy, vaccinated according to the 
Extended Program for Immunization (EPI) protocol, and had no signif-
icant past surgical history. However, he had recovered from an upper 
respiratory tract infection (URTI) with symptoms of fever, cough and 
rhinorrhea 1 week prior to the development of his current gastrointes-
tinal symptoms, for which he was seen in a polyclinic by a family 
physician and prescribed antipyretics and supportive management. 
On physical examination in the emergency room, he appeared to be a 
pale, irritable child. His heart rate was 136 beats per minute, he was 
afebrile, with an oxygen saturation of 98% and a sausage shaped lump 
palpable in the right upper abdomen. The rest of his systemic exami-
nation including the respiratory system and ENT was unremarkable. 
2.1. Investigations 
The child was found to have hypochromic microcytic anemia (Hb: 
9.2 g/dL) along with a total leucocyte count of 9.9  109/L (raised 
monocytes 12.1%). Ultrasound abdomen confirmed intussusception 
(Fig. 1). 
2.2. Management 
The patient was resuscitated in the emergency room. Broad spectrum 
intravenous antibiotics were administered (listed in Table 1) and 
pneumatic reduction of intussuscepted bowel (ileocolic intussusception) 
was performed under fluoroscopic guidance in the radiology suite after 
insufflation of air at 100 mm Hg for 3 minutes under two attempts. Free 
flow of air was observed in the large and small bowel, representing a 
successful reduction of intussusception. No immediate post procedure 
complication was noted. 
The patient was then admitted for further observation. Due to the 
ongoing pandemic and positive history of URTI one week prior, he was 
screened for SARS-CoV-2 (COVID-19) using a nasal swab (qualitative 
PCR) which was positive (Report as per CAP guidelines on 23rd March 
2020). The child had no Covid-19 contact history. 
He then underwent a chest x-ray (Fig. 2) which was normal, and his 
blood work included:  
 CRP:3.7 (0–10 mg/dL),  
 Ferritin:162.9 (22–322 ng/mL),  
 D-Dimer:3.8 (<0.5 mg/L FEU). 
The patient did not receive any treatment for COVID-19 as he was 
asymptomatic, however, the parents were advised to follow isolation 
protocols and return immediately upon the development of symptoms. 
The patient’s recovery was uneventful, and his diet was established in 24 
hours. He was discharged in a stable condition after a total hospital stay 
of 60 hours. Throughout the hospital course, he did not develop any 
respiratory symptoms or signs of sepsis and was recovering and in good 
health 1-week post-discharge. 
3. Discussion 
According to our literature review, this is only the second such 
instance of a SARS-CoV-2 positive patient presenting to a healthcare 
center with intussusception as the primary manifestation, and the first 
documented case in which the patient survived. The only other docu-
mented case was in Wuhan, China. In that particular case, the patient 
was a 10-month-old female who presented with fever, restlessness, 
vomiting and currant jelly-like stool for 30 hours. However, there were 
Fig. 1. There is evidence of telescoping of bowel within the bowel loop in right upper quadrant of abdomen in the subhepatic region giving doughnut sign. Ap-
pearances are suggestive of intussusception. 
Table 1 
Comparison of our patient with the patient reported by Cai et al.   
Moazzam et al. Cai et al. 
Underlying 
disease 
Intussusception Intussusception 
Gender Male Female 
Age 4 months, 25 days 10 months 
Exposure history None None 
First clinical 
manifestation 
Acute, intermittent, crampy 
abdominal pain, 
inconsolable crying, per 
rectal bleeding (currant 
jelly stool) 
Paroxysmal crying, vomiting, 
currant jelly-like stool 
Fever Afebrile Febrile (Maximum 
temperature  39.8 C) 
Days from onset of 
symptoms to 
admission 
2 1.25 
Complications None Shock; MODS (liver, kidney, 
myocardium, DIC, acute 
respiratory failure 
Treatment  
Surgical Pneumatic Reduction Pneumatic Reduction 
Medical   IV Co-Amoxiclav 30mg/ 
kg Q8H for 3 days  
 Amikacin 15 mg/kg QD 
for 3 days  
 Metronidazole 10 mg/kg 
Q8H for 3 days  
 Paracetamol 15 mg/kg 
Q6H 
*Patient did not receive 
treatment for any other 
COVID-19 complications  
 Intravenous ribavirin  
 Aerosol inhalation of 
interferon  
 Methylprednisolone - 2 mg/ 
(kg⋅d) for 5 days  
 Intravenous 
immunoglobulin - 500 mg/ 
(kg⋅d) for 3 days 
Length of stay 
(days) 
2.5 36 
Outcome In good health one-week 
post-discharge 
Death  
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no respiratory symptoms or exposure to COVID-19. After successful 
diagnostic air enema, the child developed a high fever, became drowsy 
and developed intermittent convulsions. Signs of multiorgan failure 
(liver, kidney and myocardium), along with disseminated intravascular 
coagulation also developed. The patient subsequently tested positive for 
SARS-CoV-2 twice in throat swab samples. Furthermore, necrosis of the 
proximal ileum was discovered with subsequent resection. On day 36, 
the patient died due to multiorgan failure [7]. A comparison of the two 
documented SARS-CoV-2 positive patients who developed intussuscep-
tion has been detailed in Table 1. 
Although gastrointestinal symptoms have been documented in 
COVID-19, they are rare and have primarily been limited to diarrhea or 
vomiting. A review of 452 patients in 23 studies revealed that diarrhea 
(6.6%) and vomiting (5.8%) were far less than common than fever 
(43.1%) or cough (43.4%) [10]. Overall, symptoms in the pediatric 
population were shown to be milder in the pediatric population in a case 
series of 2135 patients in China. When the symptoms were classified as 
asymptomatic, mild, moderate, severe or critical, the distribution was 
4.4%, 51.0%, 38.7%, 5.3% and 0.6% respectively. However, in children 
less than 1 year of age, the proportion of patients with severe or critical 
illness was markedly higher at 8.8% and 1.9%. As a result, it concluded 
that although children generally developed milder symptoms, infants in 
particular were vulnerable to severe or critical illness [11–13]. 
Furthermore, infants had higher hospitalization rates (15%–62%) 
compared to older children (1–17 years) (4.1%–14%) and adults. Mul-
tiple mechanisms for the milder symptoms have been proposed. The 
SARS-CoV-2 virus downregulates ACE2 expression thus impairing 
angiotensin-2 metabolism, which promotes lung injury. High levels of 
ACE-2 are present in children, thus they may be protective against se-
vere illness [5,14,15]. Furthermore, it has been proposed that countries 
with routine BCG vaccination have lower COVID-19 mortality and 
morbidity rates [16]. As aging occurs, the regenerative capacity of lungs 
gradually decreases, thus the lungs in children are better placed to 
recover from COVID-19 [17]. Conversely, an inadequate adaptive im-
munity response due to an immature immune system could account for 
the poorer prognosis in infants compared to young children. 
Viral shedding in COVID-19 patients primarily occurs through nasal 
secretions, however, a feco-oral route of transmission has also been 
postulated. This is supported by a study which found that 8 out of 10 
COVID-19 positive children had positive rectal swabs, even after their 
nasopharyngeal swabs had turned negative [18]. 
Intussusception may be caused by anatomical causes, associated 
diseases and pertinent to this case, viral infections. However, only 10% 
of patients have an identifiable cause of the intussusception, with the 
vast majority being idiopathic. Infections can cause mesenteric lymph-
adenopathy and hypertrophy of Peyer patches, which can act as a lead 
point for the intussusceptum. Approximately 30% of pediatric intus-
susception cases have a preceding viral illness. Adenovirus and Rota-
virus, along with some parasites, have been identified as agents which 
can cause intussusception [19]. A study from 1990 showed that rota-
virus had a seasonal peak temperate climates while being present 
throughout the year in the tropics [20]. However, a subsequent 
large-scale review demonstrated that country income level was more 
predictive of the likelihood of having seasonal disease [21]. Poliovirus, 
enterovirus, parechovirus and norovirus have also been found in the 
stool specimens of affected patients [22]. After the viral illness, children 
tend to present with acute onset colicky abdominal pain, excessive ir-
ritability, vomiting and a “currant jelly” stool due to the presence of 
blood and mucus. This course is intermittent, in that the child may re-
turn to a normal level of activity in between bouts of symptoms. 
Our case also followed a similar pattern, with a viral URTI illness 
preceding the onset of intussusceptive symptoms. This raises suspicion 
of SARS-CoV-2 directly affecting the gastrointestinal tract, leading to 
mesenteric adenitis and resulting in intussusception. This would be the 
first such reported incidence of intussusception as a manifestation of 
SARS-CoV-2 infection, with no respiratory symptoms. It is plausible that 
the respiratory symptoms that the child had one week prior were in fact 
due to SARS-CoV-2 and the intussusception episode was a delayed 
complication instead of a primary manifestation. Another explanation 
for this could be that the child had contracted an upper respiratory tract 
infection (URTI) of undocumented etiology and thus developed intus-
susception, subsequently contracting SARS-CoV-2 during the course of 
his visit to the government hospital whilst seeking treatment for his 
URTI. Furthermore, contracting SARS-CoV-2 during his stay at our 
hospital is highly unlikely, given that he was tested only 13 hours after 
admission and the child did not develop any respiratory symptoms 
during his hospital stay or in the week after discharge. 
Testing rates in the pediatric population are much lower compared to 
adults and elderly globally. The WHO, CDC and numerous government 
health agencies emphasize fever and respiratory symptoms in the testing 
criteria for suspected cases [23]. Since both of these are present in less 
than 50% of pediatric cases [10], it raises substantial concern for un-
derestimation of pediatric cases of COVID-19. As a result, testing rates 
globally must be enhanced to gauge the true disease burden and to gain 
a better understanding of the associated complications. 
4. Conclusion 
We report, to the best of our knowledge, the first documented 
instance of survival in a case of intussusception in a SARS-CoV-2 positive 
pediatric patient. Owing to the dearth of literature on this subject, 
further studies need to be conducted on the gastrointestinal complica-
tions associated with COVID-19. Since the knowledge of this virus is still 
evolving, surgeons need to remain suspicious for possible gastrointes-
tinal manifestations of SARS-CoV-2. 
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Fig. 2. Chest radiograph AP supine projection; No evidence of any active 
cardiac or pulmonary disease noted. 
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